Non-inferiority trials: why oncologists must remain wary
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference11 articles.
1. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data;Breugom;Lancet Oncol,2015
2. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group;Sargent;J Clin Oncol,2007
3. Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803;Sargent;Eur J Cancer,2011
4. No benefit of adjuvant fluorouracil leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT);Sainato;Radiother Oncol,2014
5. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study;Bosset;Lancet Oncol,2014
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Non-inferiority trials with time-to-event data: clarifying the impact of censoring;Journal of Biopharmaceutical Statistics;2023-04-12
2. Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment;BMC Medicine;2022-11-09
3. Non-inferiority in cancer clinical trials was associated with more lenient margins and higher hypothesized outcome event rates;Journal of Clinical Epidemiology;2021-11
4. Surgical clinical trials with non-inferiority design: a cross-sectional bibliometric analysis;Annals of Translational Medicine;2021-08
5. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update;Journal of Clinical Oncology;2021-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3